126 related articles for article (PubMed ID: 8915102)
1. Synthesis and smooth muscle calcium channel antagonist effects of alkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-5-[2-(4,5-dihydro- 4,4-dimethyloxazolin-2-yl)]-3-pyridinecarboxylates.
Anana RD; Knaus EE
Arch Pharm (Weinheim); 1996; 329(8-9):408-12. PubMed ID: 8915102
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
4. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pyridinyl)-3,5-pyridinedicarboxylates.
Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Wynn H; Triggle CR; Knaus EE
J Med Chem; 1986 Dec; 29(12):2524-9. PubMed ID: 3783612
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and calcium channel modulating effects of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(thienyl)-5-pyridinecarboxylates.
Miri R; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Oct; 330(9-10):290-4. PubMed ID: 9396387
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and smooth muscle calcium channel effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrone moiety in the 4-aryl substituent.
Anana RD; Ng H; Howlett SE; Knaus EE
Arch Pharm (Weinheim); 1997 Mar; 330(3):53-8. PubMed ID: 9167447
[TBL] [Abstract][Full Text] [Related]
8. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
Shan R; Velazquez C; Knaus EE
J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and smooth muscle calcium channel antagonist effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrooxy or nitrophenyl moiety in the 3-alkyl ester substituent.
Iqbal N; Knaus EE
Arch Pharm (Weinheim); 1996 Jan; 329(1):23-6. PubMed ID: 8687280
[TBL] [Abstract][Full Text] [Related]
10. Syntheses, calcium channel antagonist and anticonvulsant activities of substituted 1,4-dihydro-3,5-pyridinedicarboxylates containing various 3-alkyl ester substituents.
Yiu SH; Knaus EE
Arch Pharm (Weinheim); 1997; 330(1-2):35-43. PubMed ID: 9112813
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and calcium channel antagonist activity of dialkyl 4- (dihydropyridinyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylates.
Dagnino L; Li-Kwong-Ken MC; Wynn H; Wolowyk MW; Triggle CR; Knaus EE
J Med Chem; 1987 Apr; 30(4):640-6. PubMed ID: 3560157
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and calcium channel antagonist activity of alkyl cycloalkyl esters of nifedipine containing pyridinyl substituents.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1989 Dec; 5(2):117-23. PubMed ID: 2577981
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium channel antagonist activities of 3-nitrooxyalkyl, 5-alkyl 1,4-dihydro-2,6-dimethyl-4-(1-methyl-5-nitro-2-imidazolyl)-3, 5-pyridinedicarboxylates.
Miri R; Niknahad H; Vesal G; Shafiee A
Farmaco; 2002 Feb; 57(2):123-8. PubMed ID: 11902654
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and calcium channel antagonist activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-[3-(1-methoxy-carbonyl-4-substituted-1,4- dihydro-pyridyl)]-3,5-pyridinedicarboxylates.
Ramesh M; Matowe WC; Knaus EE; Wolowyk MW
Drug Des Discov; 1992 Jul; 8(4):313-23. PubMed ID: 1445996
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1-oxido-2-pyridyl in place of the 2-nitrophenyl moiety.
Ramesh M; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Dec; 3(4):337-41. PubMed ID: 3255335
[TBL] [Abstract][Full Text] [Related]
16. Syntheses, calcium channel agonist-antagonist modulation activities, nitric oxide release, and voltage-clamp studies of 2-nitrooxyethyl 1,4-dihydro- 2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)pyridine-5-carboxylate enantiomers.
Shan R; Howlett SE; Knaus EE
J Med Chem; 2002 Feb; 45(4):955-61. PubMed ID: 11831908
[TBL] [Abstract][Full Text] [Related]
17. Hantzsch 1,4-dihydropyridines containing a diazen-1-ium-1,2-diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release.
Nguyen JT; Velázquez CA; Knaus EE
Bioorg Med Chem; 2005 Mar; 13(5):1725-38. PubMed ID: 15698790
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of pharmacological activities of 3, 5-dialkyl 1, 4-dihydro-2,6-dimethyl-4-nitroimidazole-3, 5-pyridine dicarboxylates.
Miri R; Javidnia K; Kebriaie-Zadeh A; Niknahad H; Shaygani N; Semnanian S; Shafiee A
Arch Pharm (Weinheim); 2003 Sep; 336(9):422-8. PubMed ID: 14528490
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of alkyl 7,7-dihalo-3-methyl-5-(nitrophenyl)-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
Mojarrad JS; Vo D; Velázquez C; Knaus EE
Bioorg Med Chem; 2005 Jun; 13(12):4085-91. PubMed ID: 15911322
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4-pyridyl and 3-arylethyloxycarbonyl substituents.
Akula MR; Matowe WC; Wolowyk MW; Knaus EE
Drug Des Deliv; 1990 Dec; 7(1):11-7. PubMed ID: 2096831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
